Ascendis Pharma A/S (ASND) vs Tempus AI, Inc. (TEM)

A side-by-side comparison of Ascendis Pharma A/S and Tempus AI, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Ascendis Pharma A/S logo
ASND
Ascendis Pharma A/S
$14.16B
$228.03HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
Tempus AI, Inc. logo
TEM
Tempus AI, Inc.
$14.64B
$83.55HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT

Total return — ASND vs TEM

growth of $100 · dividends reinvested · last 2y
ASND +78.7% (+33.7%/yr)TEM +107.6% (+44.1%/yr)TEM compounded faster over this window
50100150200250Start $10020252026$179$208
ASND TEM

ASND vs TEM: by the numbers

  • •TEM is the larger company ($14.64B vs $14.16B market cap).
  • •ASND is profitable (71.08% net margin) while TEM runs a net loss (-17.77%).
  • •ASND grew revenue faster over the past five years (189.92% vs 38.24% CAGR).

Metrics side by side

Valuation

MetricASNDTEM
P/E ratio17.33N/A
P/S ratio11.5910.22
P/B ratio8.6432.90
EV / EBITDA93.79N/A
FCF yield2.73%N/A

Profitability

MetricASNDTEM
Gross margin90.18%63.98%
Operating margin-18.92%-19.76%
Net margin71.08%-17.77%
ROE52.97%-57.18%
ROIC5.85%-14.34%

Growth (annualized)

MetricASNDTEM
Revenue CAGR (5Y)189.92%38.24%
Total return CAGR (5Y)7.40%N/A

Frequently asked

Which has grown faster, ASND or TEM?
Over the past five years, ASND grew revenue faster — ASND at a 189.92% CAGR versus TEM at 38.24%.
Is ASND or TEM more profitable?
ASND runs the higher net margin — ASND at 71.08% versus TEM at -17.77%.

Go deeper

Full ASND analysisFull TEM analysisInteractive comparison tool

Dig into the metrics

Ascendis Pharma A/S P/E ratioAscendis Pharma A/S ROETempus AI ROEAscendis Pharma A/S operating marginTempus AI operating marginAscendis Pharma A/S revenue growthTempus AI revenue growthAscendis Pharma A/S free cash flowTempus AI free cash flow

Ascendis Pharma A/S & Tempus AI appear in these rankings

Fastest Revenue Growth StocksHighest ROE StocksHighest 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.